MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability

Core Insights - MaxCyte, Inc. announced a restructuring plan aimed at aligning resources with strategic priorities, which includes a workforce reduction of approximately 34% and expected annualized savings of about $13.6 million [1][2][4] Financial Outlook - The company expects 2025 core revenue to be flat to down approximately 10% compared to 2024, with an anticipated $5 million in SPL program-related revenue for the full year [3] - Year-end cash, cash equivalents, and investments are projected to be at least $155 million [3] Strategic Initiatives - The workforce reduction is part of a broader initiative to reduce operating expenses, streamline the organizational structure, and accelerate the path toward profitability [2][4] - The CEO emphasized the importance of this decision for long-term success and indicated that further details on the financial impact and outlook for the remainder of 2025 will be provided in the upcoming third quarter earnings call [4]